Geiben-Lynn R, Kursar M, Brown N V, Kerr E L, Luster A D, Walker B D
Partners AIDS Research Center and Infectious Disease Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA.
J Virol. 2001 Sep;75(17):8306-16. doi: 10.1128/jvi.75.17.8306-8316.2001.
Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes (CTL) mediate immunologic selection pressure by both cytolytic and noncytolytic mechanisms. Non cytolytic mechanisms include the release of beta-chemokines blocking entry of R5 HIV-1 strains. In addition, CD8(+) cells inhibit X4 virus isolates via release of as yet poorly characterized soluble factors. To further characterize these factors, we performed detailed analysis of CTL as well as bulk CD8(+) T lymphocytes from six HIV-1-infected individuals and from six HIV-1-seronegative individuals. Kinetic studies revealed that secreted suppressive activities of HIV-1-specific CTL and bulk CD8(+) T lymphocytes from all HIV-1-infected persons are significantly higher than that of supernatants from seronegative controls. The suppressive activity could be blocked by monensin and brefeldin A, was heat labile, and appeared in a pattern different from that of secretion of chemokines (MDC, I-309, MIP-1alpha, MIP-1beta, and RANTES), cytokines (gamma interferon, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor), and interleukins (interleukin-13 and interleukin-16). This suppression activity was characterized by molecular size exclusion centrifugation and involves a suppressive activity of >50 kDa which could be bound to heparin and a nonbinding inhibitory activity of <50 kDa. Our data provide a functional link between CD8(+) cells and CTL in the noncytolytic inhibition of HIV-1 and suggest that suppression of X4 virus is mediated through proteins. The sizes of the proteins, their affinity for heparin, and the pattern of release indicate that these molecules are not chemokines.
人类免疫缺陷病毒(HIV)特异性细胞毒性T淋巴细胞(CTL)通过细胞溶解和非细胞溶解机制介导免疫选择压力。非细胞溶解机制包括释放β趋化因子以阻断R5 HIV-1毒株的进入。此外,CD8(+)细胞通过释放目前特征尚不明确的可溶性因子来抑制X4病毒分离株。为了进一步表征这些因子,我们对来自6名HIV-1感染者和6名HIV-1血清阴性个体的CTL以及大量CD8(+) T淋巴细胞进行了详细分析。动力学研究表明,所有HIV-1感染者的HIV-1特异性CTL和大量CD8(+) T淋巴细胞分泌的抑制活性显著高于血清阴性对照的上清液。这种抑制活性可被莫能菌素和布雷菲德菌素A阻断,对热不稳定,其出现模式与趋化因子(MDC、I-309、MIP-1α、MIP-1β和RANTES)、细胞因子(γ干扰素、肿瘤坏死因子α和粒细胞-巨噬细胞集落刺激因子)以及白细胞介素(白细胞介素-13和白细胞介素-16)的分泌模式不同。通过分子大小排阻离心对这种抑制活性进行了表征,发现其涉及一种大于50 kDa且可与肝素结合的抑制活性以及一种小于50 kDa的非结合抑制活性。我们的数据在HIV-1的非细胞溶解抑制中建立了CD8(+)细胞与CTL之间的功能联系,并表明X4病毒的抑制是通过蛋白质介导的。这些蛋白质的大小、对肝素的亲和力以及释放模式表明这些分子不是趋化因子。